Here's What Key Metrics Tell Us About Medtronic (MDT) Q1 Earnings

Medtronic reported $9.76 billion in revenue for the quarter ended July 2026, exceeding consensus estimates by 3.02% with a year-over-year increase of 13.7%. EPS of $1.45 surpassed the consensus estimate of $1.39 by 4.32%. Strong performance was driven by cardiovascular (+19.5% YoY) and diabetes (+16.9% YoY) segments, though the 'Other' category declined significantly. The stock currently holds a Zacks Rank #3 (Hold) rating.